Melatonin activates cell death programs for the suppression of uterine leiomyoma cell proliferation
article
OA: closed
CC0
⤵ 8 in-corpus citations
AI-generated summary
Melatonin treatment suppressed uterine leiomyoma cell proliferation and tumor growth by activating cell death programs and down-regulating the Akt-ERK1/2-NFκB signaling pathway.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
The circadian nature of melatonin has a protective effect on the progression of female reproductive cancers, including breast and ovarian cancers. However, the effect of melatonin on the growth of uterine leiomyoma is still unclear. In this study, we found that the growth of uterine leiomyoma ELT3 cells was reduced by treatment with melatonin. Treatment with melatonin increased the distribution of sub-G1 phase and increased DNA condensation in ELT3 cells. Melatonin-induced apoptosis and autophagy cell death progression were observed in ELT3 cells. Melatonin exerts a highly selective effect on primary normal human uterine smooth muscle (UtSMC) cells. The UtSMC cell cycle was arrested by melatonin treatment through up-regulation of p21, p27, and PTEN protein expression, but melatonin did not further promote apoptosis program activation. Melatonin reduced cell proliferation in ELT3 cells underlying the activation of melatonin MT1 and MT2 receptors, which in turn down-regulated the Akt-ERK1/2-NFκB signaling pathway. Melatonin reduced ELT3 tumor growth in both xenograft and orthotopic uterine tumor mice models. The extracellular matrix of the tumor was also reduced by melatonin treatment. Taken together, these results suggest that melatonin potentially plays a role in suppression of uterine leiomyoma growth.
My notes (saved in your browser only)
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (61)
- Fucoidan Inhibits the Proliferation of Leiomyoma Cells and Decreases Extracellular Matrix-Associated Protein Expression via openalex
- Isoliquiritigenin Suppresses E2-Induced Uterine Leiomyoma Growth through the Modulation of Cell Death Program and the Repression of ECM Accumulation via openalex
- W1784425676 via openalex
- W1806289054 via openalex
- W1918114876 via openalex
- W1964477766 via openalex
- W1969018878 via openalex
- W1982659569 via openalex
- W2008379035 via openalex
- W2023211656 via openalex
- W2026605955 via openalex
- W2031926129 via openalex
- W2032518219 via openalex
- W2047196174 via openalex
- W2053717292 via openalex
- W2055811314 via openalex
- W2074489279 via openalex
- W2076343978 via openalex
- W2090740247 via openalex
- W2096090206 via openalex
- W2115886998 via openalex
- W2116836791 via openalex
- W2120027464 via openalex
- W2120854324 via openalex
- W2127303641 via openalex
- W2131278010 via openalex
- W2142490215 via openalex
- W2161919679 via openalex
- W2169959327 via openalex
- W2170181695 via openalex
- W2171426197 via openalex
- W2226020513 via openalex
- W2342379115 via openalex
- W2419200598 via openalex
- W2479394673 via openalex
- W2510435007 via openalex
- W2510982895 via openalex
- W2574859291 via openalex
- W2595206985 via openalex
- W2597174991 via openalex
- W2616902179 via openalex
- W2621351973 via openalex
- W2753057473 via openalex
- W2757308637 via openalex
- W2766040319 via openalex
- W2770132733 via openalex
- W2790484942 via openalex
- W2804911874 via openalex
- W2808206896 via openalex
- W2896953669 via openalex
- W2917769420 via openalex
- W2926178629 via openalex
- W2938772210 via openalex
- W2939092027 via openalex
- W4210998728 via openalex
- W6641177053 via openalex
- W6652575643 via openalex
- W6673219787 via openalex
- W628796965 via openalex
- W6735379238 via openalex
- W1547736903 via openalex
Cited by (8)
- The Effect of Melatonin on Endometrial Histology in Patients with Endometrial Proliferative Disorders: A Double-Blind Randomized Clinical Trial 2025
- Melatonin: Current evidence on protective and therapeutic roles in gynecological diseases 2024
- Strategic Suppression of Nicotinamide Phosphoribosyl Transferase for Uterine Leiomyoma Progression Modulation 2024
- QUALITY OF LIFE AND PLASMA LEVELS OF MELATONIN AND STEROID HORMONES IN WOMEN WITH UTERINE LEIOMYOMA 2024
- Regulatory roles of NAMPT and NAD+ metabolism in uterine leiomyoma progression: Implications for ECM accumulation, stemness, and microenvironment 2024
- Levels of melatonin and some indicators of angiogenesis, antioxidant system and lipid peroxidation in blood plasma in women with uterine leiomyoma 2024
- Potential Effects of Melatonin on the Development of Uterine Fibroids in Women of Reproductive Age (Review of Literature) 2021
- The effects of isoliquiritigenin on endometriosis in vivo and in vitro study 2020
Source provenance
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- unpaywall
- last seen: 2026-06-02T02:00:03.124865+00:00
License: CC0
· commercial use OK